Fast new swab test could speed up vaginitis diagnosis

NCT ID NCT07607470

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study will test a new diagnostic device called the Nanopath assay, which aims to quickly detect bacteria or yeast causing vaginitis. Up to 1000 women with symptoms like itching or discharge will provide vaginal swab samples, either collected by a clinician or themselves. The goal is to see how well the new test compares to existing FDA-cleared tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nanopath Vaginitis Assay (diagnostic test)
What this could lead to
If successful, this could provide a faster, simpler test for diagnosing vaginal infections, potentially improving treatment decisions.
What could go wrong
This is an early pilot study focused on algorithm development, not a treatment trial. The test may not prove accurate enough or may not be adopted in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • LSU-CrescentCare Sexual Health Center

    RECRUITING

    New Orleans, Louisiana, 70119, United States

  • Segal Trials

    RECRUITING

    North Miami, Florida, 33161, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.